BioGaia signs new agreement with Ferring Pharmaceuticals

22-Feb-2008

BioGaia has signed a new agreement with the Swiss biopharmaceutical company Ferring Pharmaceuticals. The agreement gives Ferring exclusive rights to sell BioGaia´s Probiotic Drops in Australia, New Zealand and Israel as well as BioGaia´s Probiotic Tablets in Brazil, Egypt, Greece, Iran, Jordan, Canada, Lebanon, Mexico, Saudi Arabia and Syria. The collaboration, which was first initiated in spring 2006, has been so successful that, as well as extending the duration of the agreement, Ferring will be marketing BioGaia's Probiotic Drops in additional markets and adding a tablet form of the treatment to its product portfolio.

The drops have already been launched in Spain, Portugal, The Czech Republic and Canada and it is expected that they will be launched in Jordan and Mexico during the first quarter 2008. Ferring has further exclusive rights to sell BioGaia's Probiotic Drops in Brazil, Egypt, Greece, Iran, Lebanon, Saudi Arabia and Syria.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances